Codex DNA - Tools for Addressing the SARS-CoV-2 Virus

SARS-CoV-2 RNA Controls

Positive controls are useful as quality control measures for the verification and validation of both next-generation sequencing (NGS) and reverse transcriptase-polymerase chain reaction (RT-PCR) diagnostic assays.

Codex offers synthetic SARS-CoV-2 RNA controls and supports collaborators with materials to develop their own.


SARS-CoV-2 Full-Length Synthetic Genome

The only next-generation bacterial expression system.Codex offers a SARS-CoV-2 full-length synthetic genome (Wuhan-Hu-1 strain; GenBank number MN908947.3) cloned in a bacterial artificial chromosome that can be leveraged for the development of vaccines, therapeutics, and diagnostics. Genome modifications and editing are available.


SARS-CoV-2 Antibody Libraries

Rapidly design and generate antibody libraries for the development of therapeutics using the BioXp™ system.

Click here to see more about Codex DNA SARS-CoV-2 tools

 

Enquiry Form

Required fields are marked with*